In this review:
Apremilast effective in Behçet’s syndrome
Increased risk of MI in systemic sclerosis
Using a brace for patellofemoral OA
Ustekinumab inhibits radiographic progression in PsA
Tabalumab: no clear clinical benefit in RA
Mavrilimumab improves pain, function, DAS28 in RA
DEKAVIL: targeted delivery of IL10 may benefit RA
Revived interest in triple therapy
Cost-effective data favour triple vs etanercept strategies
Rituximab effective in IgG4-related disease
SC methotrexate auto-injector looks promising
PRIZE study data: the effects of treatment withdrawal
Please login below to download this issue (PDF)